EMAIL DETAILS
SUBJECT:
Re: follow up
PRI: NORMAL
FROM:
2
261penn@gmail.com
DATE:
2015-04-06 14:08:33
MSG_ID:
<4D41A8DF-59DA-4164-AAE6-58A274E802BC@gmail.com>
RECIPIENTS:
TO:
W
Yung,W K Alfred
<wyung@mdanderson.org>
CC:
H
halliebiden@gmail.com
H
hbiden@rosemontseneca.com
H
Howard Krein
<howard.krein@jefferson.edu>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
4/15-16? 4/16-17? 4/19-20? Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege. > On Mar 30, 2015, at 5:16 PM, Yung,W K Alfred <wyung@mdanderson.org> wrote: > > I talked to Fred Lang this morning. We can skip the D4 visit. We will do it by phone. Beau just need to return in Day 14 (4/16) for a MRI and the anti-PD1 infusion. > Al > > > W.K. Alfred Yung, M.D. > Chairman, Department of Neuro-Oncology > Margaret and Ben Love Chair in Clinical Cancer Care > UT M. D. Anderson Cancer Center, Unit 431 > 1515 Holcombe Blvd > Houston, TX 77030 > Tele: 713-794-1285 > Fax: 713-563-0151 > wyung@mdanderson.org > =2
METADATA:
THREAD:
INDEX:
AdhhnZ8sh0hDN/jMTViB1Lf1MzdlTw==
REFERENCES:
REPLY_TO:
<E92355D42D753546BBE0D1DA4FEF8F0315F6B846@DCPWPEXMBX02.mdanderson.edu>
REFS:
<E92355D42D753546BBE0D1DA4FEF8F0315F6B846@DCPWPEXMBX02.mdanderson.edu>